hyoscyamine sulfate 0.125 MG Sublingual Tablet [Levsin]

RxCUI
1047908
RxNorm name
hyoscyamine sulfate 0.125 MG Sublingual Tablet [Levsin]
Display name
LEVSIN (Sublingual)
Full name
hyoscyamine sulfate 0.125 MG Sublingual Tablet [Levsin]
Term type
SBD
Status
Active
Strength
0.125 mg
Dose form
Tab
Route
Sublingual
Updated
2026-08-03 17:30:22

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012011
Active start
012011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
hyoscyamine sulfate0.125 MG / 1 EACHhyoscyaminehyoscyamine sulfate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Sublingual Tablet317007

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
hyoscyamine153970

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRLevsin 0.125 MG Sublingual Tablet1NAMES
RxNorm Namehyoscyamine sulfate 0.125 MG Sublingual Tablet [Levsin]1NAMES
RxNorm SynonymLevsin 0.125 MG Sublingual Tablet1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_IDf38ece41-b890-11e2-9e96-0800200c9a661CODES
RxCUI10479081CODES
MMSL_CODEBD52651CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
68220-113-1068220-113Levsin hyoscyamine sulfateViatris Specialty LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 10 matching rows.

NDC11, Source, Active table
NDC11SourceActive
68220011310rxnav_ndcsyes
68220011350rxnav_ndcsyes
00091353201rxnav_historical
00091353205rxnav_historical
00091353299rxnav_historical
53978337209rxnav_historical
54868176700rxnav_historical
58056035210rxnav_historical
62584000700rxnav_historical
65084020410rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levsin SLHYOSCYAMINE SULFATEViatris Specialty LLCf38ece41-b890-11e2-9e96-0800200c9a662013-05-14Warnings, Adverse reactionsExact identifier
ndc (package): 68220-113-10
ndc (product): 68220-113
ndc11 (package): 68220011310
rxcui: 1047908

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f38ece41-b890-11e2-9e96-0800200c9a66Levsin SL 0.125 MG Sublingual Tablet [PSN] · hyoscyamine sulfate 0.125 MG Sublingual Tablet [Levsin] [SBD] · Levsin 0.125 MG Sublingual Tablet [SY]36Levsin ® /SL tablets (hyoscyamine sulfate tablets USP) Rx Only 201092-01 Rev. 07/202520130514

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
31042fe5-c0f8-41d0-8d8f-127237cecd0fNational Council for Prescription Drug Programs20130604
7ae0fdaf-0379-4c52-a788-40fa59cb508aNational Council for Prescription Drug Programs20130604
f38ece41-b890-11e2-9e96-0800200c9a66Levsin ® /SL tablets (hyoscyamine sulfate tablets USP) Rx Only 201092-01 Rev. 07/2025Viatris Specialty LLC20130514

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4hyoscyamine
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine sulfate
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine sulfate
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine sulfate
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine sulfate
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine sulfate
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine sulfate
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine sulfate
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine sulfate
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine sulfate
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine sulfate
MEDRTD014202TremorDISEASEmay_treathyoscyamine
MEDRTD014202TremorDISEASEmay_treathyoscyamine sulfate
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine sulfate
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine sulfate
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.125 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable SynonymLevsin SL 0.125 MG Sublingual Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon